Here we show that a replication-defective virus-vectored TB vaccine administered via the respiratory mucosal route induces Ag-specific TRM in the lung characterized by high-level expression of TRM surface markers VLA-1 and CD103. The gene discussed is ITGA1; the disease is tuberculosis.